Chennai-based Lifecell International (P) Ltd and the US based medical device company, Harvest Technologies, have received the approval from DCGI for promoting BMAC (Bone marrow aspirate concentrate) kits in Indian Market.
Sources from the Lifecell said BMAC System is an easy to use, point of care, autologous system that can rapidly produce a concentration of mononuclear cells (MNC) consistent with those concentrate reported in numerous human clinical trials. Existing methods to produce a stem cell concentrate therapy are time consuming, labour intensive, and require complex logistical considerations.
The BMAC System conveniently processes either 60mls or 120mls of bone marrow aspirate within a 15 minute process step that can be conducted in the point of care setting. It produces a MNC concentrate that is unsurpassed in the number of cells the system can yield as well as ensuring that the cells remain viable during the process. A typical yield from processing just 60mls of aspirate is over 220 million MNC’s of which approximately 10 million are CD34+ with over 3200 Colony Forming Units (CFU’s).
Read More.....
Lifecell wrinkle cream provides microscopic 3D crystals which reflect light so that you cannot see the wrinkle. The results is that wrinkles become invisible within minutes after applying the cream.
Revitaderm Cream
Post a Comment